$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%$CRCL-20.11%$NBIS+0.67%called by @SteveUrkelDude$AXTI+6.21%called by @PolarizingLit$SNDK0.00%$ONTO+4.61%$RKLB-2.84%called by @SteveUrkelDude$GEV+3.03%$NKTR-1.86%called by @LTbioinvestor$MP+0.02%$ALAB-1.70%$AAOI+18.94%called by @MarcJacksonLA$AMD+1.33%$INTC+0.11%$CRML-3.27%$AEHR+5.49%called by @RodmanM1$MU-2.18%called by @SteveUrkelDude$OPTX+4.09%
Morning BriefingTuesday, Jun 9, 2026
Buy Zone5 picks: ONDS, SMCI, NVTS…
Exit Alerts0 warnings issued
Fear & GreedGREED67
SPY ETF+0.78% (Pre-Market)
Livesync 0s ago
Callers
Single-call
Leaderboard #258

@youngallien

Was 20 days early on $STRO. A single call this early is luck or genius — we track until we know which.

View @youngallien on X
Score
0.167
0.5+ = strong
Best lead
20d
on $STRO
Winners
1
single call
Pre-run tweets
1
substantive only

Calls breakdown

$STROCalled 20 days before runRunning
first mention: Jul 6, 2024
“$STRO . Biotech with over $6/share in cash trading under $4. Prospects for the drug are good. Lots of very smart biotech investors onboard. Company has plenty of money to get through phase 3 on its ovarian cancer drug. The company has licensing deals with $PCVX , $MRK , and Astellas. $PCVX is a $6B ”
View tweet
6 other callers also flagged $STRO pre-run:
PY
@pythoninvestor
MA
@MarcJacksonLA
JA
@JacobPlieth
N_
@n_hatami
JB
@jbdotdotdot
SU
@SutroBio